Correlation Between Chimerix and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Chimerix and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chimerix and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chimerix and Tscan Therapeutics, you can compare the effects of market volatilities on Chimerix and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chimerix with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chimerix and Tscan Therapeutics.
Diversification Opportunities for Chimerix and Tscan Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Chimerix and Tscan is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Chimerix and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Chimerix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chimerix are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Chimerix i.e., Chimerix and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Chimerix and Tscan Therapeutics
Given the investment horizon of 90 days Chimerix is expected to under-perform the Tscan Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Chimerix is 1.39 times less risky than Tscan Therapeutics. The stock trades about -0.15 of its potential returns per unit of risk. The Tscan Therapeutics is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 508.00 in Tscan Therapeutics on September 3, 2024 and sell it today you would lose (31.00) from holding Tscan Therapeutics or give up 6.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Chimerix vs. Tscan Therapeutics
Performance |
| Timeline |
| Chimerix |
| Tscan Therapeutics |
Chimerix and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chimerix and Tscan Therapeutics
The main advantage of trading using opposite Chimerix and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chimerix position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Chimerix vs. Assembly Biosciences | Chimerix vs. Spero Therapeutics | Chimerix vs. Achilles Therapeutics PLC | Chimerix vs. Instil Bio |
| Tscan Therapeutics vs. DiaMedica Therapeutics | Tscan Therapeutics vs. Lyra Therapeutics | Tscan Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |